Meeting of the shareholders 1/2018 on April 25, 2018, the executives of Blue Finix has reported in the meeting regarding the loss performance. Therefore, the shareholders have directed the executives of
executives of Blue Finix has reported in the meeting regarding the loss performance. Therefore, the shareholders have directed the executives of Blue Finix to prepare business recovery plan. Then, the
, the shareholders have directed the executives of Blue Finix to prepare business recovery plan. Then, the executives of Blue Finix has proposed such plan in the Board of Directors’ meeting 3/2018 on May
. Therefore, the shareholders have directed the executives of Blue Finix to prepare business recovery plan. Then, the executives of Blue Finix has proposed such plan in the Board of Directors’ meeting 3/2018 on
performance. Therefore, the shareholders have directed the executives of Blue Finix to prepare business recovery plan. Then, the executives of Blue Finix has proposed such plan in the Board of Directors
) other income including trademark and trade name fees of DEAN & DELUCA of 189 million Baht (2% of total revenues); significantly decreased by 76.5% as compared to the year 2016 of 803 million Baht. The
under trademark “Wuttisak Clinic” the Company has change the business strategy for appropriate with the business environment by closed 7 departments which have accumulate loss in July 2019 and decreased
Manufacturing under the Company’s trademark or per customers’ demand • Catering services such as parties, wedding receptions, restaurants or any events • Pop-up store sales in various locations Dessert Café Non